Trial Profile
A multicenter phase I/II study of irinotecan (CPT-11) and S-1 combination chemotherapy for metastatic colorectal cancer (CRC)
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Feb 2009
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 03 Feb 2009 New trial record.